Debut Plus

₹2.1

▲ +0.05 +2.44%

17 Jul 2026

BSE Listed

Evoq Remedies Limited (543500)

Volume: 24,000Avg Vol 1W: 49,600Avg Vol 1M: 74,72752W Range:₹1.98₹6.11
BSE www.evoqremedies.com
Key Ratios
Checked just now
Market Cap₹24 Cr
Current Price₹2.1
Previous Close₹2.05
High / Low (52w)₹6.11 / ₹1.98
Volume24,000
Avg Vol (1W)49,600
Avg Vol (1M)74,727
Stock P/E314.67
Book Value₹18.56
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B0.51
Debt / Equity0.06
50 DMA₹2.82
200 DMA₹3.36
Day change+2.44%
Price Chart
₹2.1▼ 53.23% · 1Y
₹6₹216.5L
2025-07-17
2026-07-17

20-day avg volume: 77K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 125% YoY.
  • Stock trades below its book value.
Cons
  • Stock trades at a high P/E of 315.
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹3 Cr₹9 Cr₹10 Cr₹17 Cr₹26 Cr₹6 Cr₹14 Cr
EBITDA₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹2 Cr₹0 Cr₹0 Cr
EPS0.1607150.71.190.330.04
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹2 Cr₹6 Cr₹8 Cr₹33 Cr₹35 Cr₹37 Cr₹50 Cr
Total Liabilities₹2 Cr₹6 Cr₹7 Cr₹10 Cr₹10 Cr₹12 Cr₹5 Cr
Equity₹0 Cr₹0 Cr₹1 Cr₹23 Cr₹25 Cr₹25 Cr₹45 Cr
Total Debt———————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹-26 Cr₹-4 Cr₹5 Cr₹-15 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹29 Cr₹1 Cr₹-5 Cr₹15 Cr
Free Cash Flow₹0 Cr₹-26 Cr₹-4 Cr₹5 Cr₹-15 Cr
Shareholding
Promoter 0.02% Institutions 0% Public 99.98%
Efficiency & Working Capital
ROCE—
Interest Coverage0
Dividend Payout—
Debtor Days268 d
Inventory Days69 d
Payable Days109 d
Cash Conversion Cycle228 d
Working Capital Days336 d
Shareholding Details

As of 2026-03-31

Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge0%
No. of Shareholders1,655
Shareholding Pattern

Quarterly — figures in %. Latest 11 quarters.

PeriodFeb 2022Mar 2022Sept 2022Mar 2023Sept 2023Mar 2024Jun 2024Sept 2024Mar 2025Sept 2025Mar 2026
Promoters100%73.5%73.5%73.5%73.5%20.5%11.2%11.2%11.2%11.2%0%
FIIs0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%
Public0%26.5%26.5%26.5%26.5%79.5%88.8%88.8%88.8%88.8%100%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders78247277077271,6721,5881,5771,7231,6791,655
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Dhruv GanjiPublic Shareholding11.4%28,25,000
Prashant SevantikarPublic Shareholding11.4%28,25,000
Surya Prakash JethliaPublic Shareholding2.6%6,52,000
Nilesh M SuhagiyaPublic Shareholding2.1%5,20,000
Anand MohanPublic Shareholding1.5%3,80,000
Yashiv Holdings Private LimitedPublic Shareholding1.5%3,64,000
Pattabiraman N RPublic Shareholding1.4%3,48,000
Gayathri RadhakrishnanPublic Shareholding1%2,60,000
Ambalal Karamshibhai SenghaniPublic Shareholding1%2,60,000
Bhumishth Narendrabhai PatelShareholding of Promoter and Promoter Group0%3,574
Narendrakumar Gangaramdas PatelShareholding of Promoter and Promoter Group0%71
Patel Payal BhumishthShareholding of Promoter and Promoter Group0%71
Sushilabahen Narendrakumar PatelShareholding of Promoter and Promoter Group0%71
Dahyabhai Mafatlal PatelShareholding of Promoter and Promoter Group0%71
Auxilia Pharmaceuticals Private LimitedShareholding of Promoter and Promoter Group0%71
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Bhumishth Narendrabhai Patel00%2026-03-31
Narendrakumar Gangaramdas Patel00%2026-03-31
Patel Payal Bhumishth00%2026-03-31
Sushilabahen Narendrakumar Patel00%2026-03-31
Dahyabhai Mafatlal Patel00%2026-03-31
Auxilia Pharmaceuticals Private Limited00%2026-03-31
Dhruv Ganji00%2026-03-31
Prashant Sevantikar00%2026-03-31
Surya Prakash Jethlia00%2026-03-31
Nilesh M Suhagiya00%2026-03-31
Anand Mohan00%2026-03-31
Pattabiraman N R00%2026-03-31
Board of Directors
NameDesignationYear
Bhumishth Narendrabhai PatelExecutive Director & MD2025
Narendrakumar Gangaramdas PatelNon Executive Director2025
Harsh KothariIndependent Director2025
Aesha Harsh ShahIndependent Director2025
Pushpa JoshiIndependent Director2025
Nikita JainCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10252525
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500031623
20250003714
2025000077
Substantial Acquisitions (SAST)

7 disclosure(s)

Market21/10/2025 · 5,36,000
Market20/10/2025 · 7,52,000
Market17/10/2025 · 14,40,000
Market11/01/2024 · 18,48,000
Market11/01/2024 · 30,60,000
Market10/01/2024 · 11,48,000
Company Information
Incorporated2010
AuditorH Thakkar & Co. LLP
Investor Email[email protected]
🌐 www.evoqremedies.com ↗

📍 F-12-A 1st Floor V R Complex, Nr.Sanathal Cross Road Santhal, Ahmedabad, Gujarat, 382210

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Ekennis Software ServiceGateway DistriparksGMR Power & Urban InfraBhatia Colour Chem LimitedMotherson Sumi WiringAchyut Healthcare LimitedVeranda Learning SolutionsSunrise Efficient MarketiDhyaani Tradeventtures LimitedHariom Pipe IndustriesEighty Jewellers LimitedShashwat Furnishing SolutAll “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Evoq Remedies Limited Share Price, Market Cap, P/E, Results & Fundamentals — NSE — / BSE 543500 | Debut Plus